Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 433

1.

Nonrandomized comparison between definitive chemoradiotherapy and radical surgery in patients with T(2-3)N(any) M(0) squamous cell carcinoma of the esophagus.

Hironaka S, Ohtsu A, Boku N, Muto M, Nagashima F, Saito H, Yoshida S, Nishimura M, Haruno M, Ishikura S, Ogino T, Yamamoto S, Ochiai A.

Int J Radiat Oncol Biol Phys. 2003 Oct 1;57(2):425-33.

PMID:
12957254
[PubMed - indexed for MEDLINE]
2.

Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients.

Liao Z, Zhang Z, Jin J, Ajani JA, Swisher SG, Stevens CW, Ho L, Smythe R, Vaporciyan AA, Putnam JB Jr, Walsh GL, Roth JA, Yao JC, Allen PK, Cox JD, Komaki R.

Int J Radiat Oncol Biol Phys. 2004 Dec 1;60(5):1484-93.

PMID:
15590179
[PubMed - indexed for MEDLINE]
3.

A single institutional non-randomized retrospective comparison between definitive chemoradiotherapy and radical surgery in 82 Japanese patients with resectable esophageal squamous cell carcinoma.

Yamashita H, Nakagawa K, Yamada K, Kaminishi M, Mafune K, Ohtomo K.

Dis Esophagus. 2008;21(5):430-6. doi: 10.1111/j.1442-2050.2007.00793.x.

PMID:
19125797
[PubMed - indexed for MEDLINE]
4.

Influence of hemoglobin levels on survival after radical treatment of esophageal carcinoma with radiotherapy.

Valencia Julve J, Alonso Orduña V, Escó Barón R, López-Mata M, Méndez Villamón A.

Clin Transl Oncol. 2006 Jan;8(1):22-30.

PMID:
16632436
[PubMed - indexed for MEDLINE]
5.

Neoadjuvant concurrent chemoradiotherapy followed by definitive high-dose radiotherapy or surgery for operable thoracic esophageal carcinoma.

Murakami M, Kuroda Y, Okamoto Y, Kono K, Yoden E, Kusumi F, Hajiro K, Matsusue S, Takeda H.

Int J Radiat Oncol Biol Phys. 1998 Mar 15;40(5):1049-59.

PMID:
9539559
[PubMed - indexed for MEDLINE]
6.

Multicenter prospective randomized trial comparing standard esophagectomy with chemoradiotherapy for treatment of squamous esophageal cancer: early results from the Chinese University Research Group for Esophageal Cancer (CURE).

Chiu PW, Chan AC, Leung SF, Leong HT, Kwong KH, Li MK, Au-Yeung AC, Chung SC, Ng EK.

J Gastrointest Surg. 2005 Jul-Aug;9(6):794-802.

PMID:
16187480
[PubMed - indexed for MEDLINE]
7.

Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.

Jin J, Liao Z, Zhang Z, Ajani J, Swisher S, Chang JY, Jeter M, Guerrero T, Stevens CW, Vaporciyan A, Putnam J Jr, Walsh G, Smythe R, Roth J, Yao J, Allen P, Cox JD, Komaki R.

Int J Radiat Oncol Biol Phys. 2004 Oct 1;60(2):427-36.

PMID:
15380576
[PubMed - indexed for MEDLINE]
8.

Mature survival results with preoperative cisplatin, protracted infusion 5-fluorouracil, and 44-Gy radiotherapy for esophageal cancer.

Kleinberg L, Knisely JP, Heitmiller R, Zahurak M, Salem R, Burtness B, Heath EI, Forastiere AA.

Int J Radiat Oncol Biol Phys. 2003 Jun 1;56(2):328-34.

PMID:
12738305
[PubMed - indexed for MEDLINE]
9.

Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus.

Stahl M, Stuschke M, Lehmann N, Meyer HJ, Walz MK, Seeber S, Klump B, Budach W, Teichmann R, Schmitt M, Schmitt G, Franke C, Wilke H.

J Clin Oncol. 2005 Apr 1;23(10):2310-7. Erratum in: J Clin Oncol. 2006 Jan 20;24(3):531.

PMID:
15800321
[PubMed - indexed for MEDLINE]
10.

Postoperative chemotherapy vs chemoradiotherapy for thoracic esophageal cancer: a prospective randomized clinical trial.

Tachibana M, Yoshimura H, Kinugasa S, Shibakita M, Dhar DK, Ueda S, Fujii T, Nagasue N.

Eur J Surg Oncol. 2003 Sep;29(7):580-7.

PMID:
12943623
[PubMed - indexed for MEDLINE]
11.

First-line chemotherapy improves the resection rate and long-term survival of locally advanced (T4, any N, M0) squamous cell carcinoma of the thoracic esophagus: final report on 163 consecutive patients with 5-year follow-up.

Ancona E, Ruol A, Castoro C, Chiarion-Sileni V, Merigliano S, Santi S, Bonavina L, Peracchia A.

Ann Surg. 1997 Dec;226(6):714-23; discussion 723-4.

PMID:
9409570
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Prospective comparison of surgery alone and chemoradiotherapy with selective surgery in resectable squamous cell carcinoma of the esophagus.

Ariga H, Nemoto K, Miyazaki S, Yoshioka T, Ogawa Y, Sakayauchi T, Jingu K, Miyata G, Onodera K, Ichikawa H, Kamei T, Kato S, Ishioka C, Satomi S, Yamada S.

Int J Radiat Oncol Biol Phys. 2009 Oct 1;75(2):348-56. doi: 10.1016/j.ijrobp.2009.02.086.

PMID:
19735862
[PubMed - indexed for MEDLINE]
13.

Treatment results of chemoradiotherapy for clinical stage I (T1N0M0) esophageal carcinoma.

Yamada K, Murakami M, Okamoto Y, Okuno Y, Nakajima T, Kusumi F, Takakuwa H, Matsusue S.

Int J Radiat Oncol Biol Phys. 2006 Mar 15;64(4):1106-11.

PMID:
16504758
[PubMed - indexed for MEDLINE]
14.

Chemoradiotherapy for T3 and T4 squamous cell carcinoma of the esophagus using low-dose FP and radiation: a preliminary report.

Fujiwara Y, Kamikonya N, Inoue T, Koishi K, Yoshikawa R, Nakao K, Yagyu R, Nishiwaki M, Fujiwara M, Kojima S, Nakagawa K, Yamamura T.

Oncol Rep. 2005 Nov;14(5):1177-82.

PMID:
16211282
[PubMed - indexed for MEDLINE]
15.

Comparison between chemoradiation protocol intended for organ preservation and conventional surgery for clinical T1-T2 esophageal carcinoma.

Murakami M, Kuroda Y, Nakajima T, Okamoto Y, Mizowaki T, Kusumi F, Hajiro K, Nishimura S, Matsusue S, Takeda H.

Int J Radiat Oncol Biol Phys. 1999 Sep 1;45(2):277-84.

PMID:
10487546
[PubMed - indexed for MEDLINE]
16.

Expression of epidermal growth factor receptor and proliferating cell nuclear antigen predicts response of esophageal squamous cell carcinoma to chemoradiotherapy.

Hickey K, Grehan D, Reid IM, O'Briain S, Walsh TN, Hennessy TP.

Cancer. 1994 Sep 15;74(6):1693-8.

PMID:
7915963
[PubMed - indexed for MEDLINE]
17.

[A prospective study of combined chemoradiotherapy followed by surgery in the treatment of esophageal carcinoma].

An FS, Huang JQ, Xie YT, Chen SH, Rong TH.

Zhonghua Zhong Liu Za Zhi. 2003 Jul;25(4):376-9. Chinese.

PMID:
12921571
[PubMed - indexed for MEDLINE]
18.

Concurrent chemoradiotherapy or endoscopic stenting for advanced squamous cell carcinoma of esophagus: a case-control study.

Wong SK, Chiu PW, Leung SF, Cheung KY, Chan AC, Au-Yeung AC, Griffith JF, Chung SS, Ng EK.

Ann Surg Oncol. 2008 Feb;15(2):576-82. Epub 2007 Dec 5.

PMID:
18057993
[PubMed - indexed for MEDLINE]
19.

Impact on survival of surgery after concomitant chemoradiotherapy for locally advanced cancers of the esophagus.

Hennequin C, Gayet B, Sauvanet A, Blazy A, Perniceni T, Panis Y, Mal F, Sarfati E, Valleur P, Belghiti J, Fekete F, Maylin C.

Int J Radiat Oncol Biol Phys. 2001 Mar 1;49(3):657-64.

PMID:
11172946
[PubMed - indexed for MEDLINE]
20.

Long-term outcome of phase II trial evaluating chemotherapy, chemoradiotherapy, and surgery for locoregionally advanced esophageal cancer.

Swisher SG, Ajani JA, Komaki R, Nesbitt JC, Correa AM, Cox JD, Lahoti S, Martin F, Putnam JB, Smythe WR, Vaporciyan AA, Walsh GL, Roth JA.

Int J Radiat Oncol Biol Phys. 2003 Sep 1;57(1):120-7.

PMID:
12909224
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk